Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
"GLP-1 receptor agonist medications should be started at the lowest dose, and escalated as tolerated or indicated." The case study points out the importance of testing for elevated blood ketones for those with type 1 using a GLP-1
Harlan Krunholz, MD wrote previously for Forbes about how a Cochrane review of studies on the efficacy and safety of Tamiflu found that "the manufacturer of the drug sponsored all the trials and the reviewers found evidence of publication and reporting biases." He added that "With so much at stake I was surprised that there had been no prospective, placebo-controlled trials conducted that were funded by an independent source." Looks like more independent scientific studies may be necessary before making more definitive conclusions about the safety of Tamiflu
has taken or is taking a GLP-1 agonist
If a drug is on the formulary, it will be covered
